Immunostimulating Commensal Bacteria and Their Potential Use as Therapeutics DOI Open Access
Bonita McCuaig,

Yoshiyuki Goto

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(21), P. 15644 - 15644

Published: Oct. 27, 2023

The gut microbiome is intimately intertwined with the host immune system, having effects on systemic system. Dysbiosis of has been linked not only to gastrointestinal disorders but also conditions skin, lungs, and brain. Commensal bacteria can affect status through a stimulation innate training adaptive competitive exclusion pathogens. improve response production immunomodulating compounds such as microbe-associated molecular patterns (MAMPs), short-chain fatty acids (SCFAs), secondary bile acids. microbiome, especially when in dysbiosis, plastic be manipulated introduction beneficial or adjustment nutrients stimulate expansion taxa. complex nature tract (GIT) ecosystem complicates use these methods, similar treatments have various results individuals different residential microbiomes differential health statuses. A more complete understanding interaction between commensal species, genetics, system needed for effective interventions developed implemented clinical setting.

Language: Английский

Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications DOI Creative Commons
Sonia Facchin, Luisa Bertin, Erica Bonazzi

et al.

Life, Journal Year: 2024, Volume and Issue: 14(5), P. 559 - 559

Published: April 26, 2024

The gastrointestinal tract is home to trillions of diverse microorganisms collectively known as the gut microbiota, which play a pivotal role in breaking down undigested foods, such dietary fibers. Through fermentation these food components, short-chain fatty acids (SCFAs) acetate, propionate, and butyrate are produced, offering numerous health benefits host. production absorption SCFAs occur through various mechanisms within human intestine, contingent upon types fibers reaching specific engaged fermentation. Medical literature extensively documents supplementation SCFAs, particularly butyrate, treatment gastrointestinal, metabolic, cardiovascular, gut-brain-related disorders. This review seeks provide an overview dynamics involved gut. Additionally, it will focus on roles promoting metabolic health, well their current therapeutic implications.

Language: Английский

Citations

51

Short-chain Fatty Acids and Human Health: from Metabolic Pathways to Current Therapeutic Implication DOI Open Access
Sonia Facchin, Luisa Bertin, Erica Bonazzi

et al.

Published: March 27, 2024

The gastrointestinal tract is colonized by trillions of different microorganisms, named the gut microbiota, which key to degrade undigested food such as dietary fibers. fermentation these components leads production short-chain fatty acids (SCFA) acetate, propionate, and butyrate, exploit several beneficial roles for host’s health. Their absorption happen in ways human intestine depend on type fiber reaching microorganisms involved fermentation. supplementation SCFAs, mostly treating gastrointestinal, metabolic, cardiovascular, gut-brain-related diseases has been reported medical literature. This review aims give an overview dynamics butyrate gut, with a final focus role played SCFAs metabolic health present therapeutic implications.

Language: Английский

Citations

32

Understanding Autoimmunity: Mechanisms, Predisposing Factors, and Cytokine Therapies DOI Open Access
Farzana Yasmeen, Rameez Hassan Pirzada, Bilal Ahmad

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(14), P. 7666 - 7666

Published: July 12, 2024

Autoimmunity refers to an organism’s immune response against its own healthy cells, tissues, or components, potentially leading irreversible damage vital organs. Central and peripheral tolerance mechanisms play crucial roles in preventing autoimmunity by eliminating self-reactive T B cells. The disruption of immunological tolerance, characterized the failure these mechanisms, results aberrant activation autoreactive lymphocytes that target self-tissues, culminating pathogenesis autoimmune disorders. Genetic predispositions, environmental exposures, immunoregulatory disturbances synergistically contribute susceptibility initiation pathologies. Within realm therapies for diseases, cytokine have emerged as a specialized strategy, targeting cytokine-mediated regulatory pathways rectify imbalances. Proinflammatory cytokines are key players inducing propagating inflammation, highlighting potential managing conditions. This review discusses etiology current therapeutic approaches, prospects future drug design.

Language: Английский

Citations

19

A Comprehensive Review of the Triangular Relationship among Diet–Gut Microbiota–Inflammation DOI Open Access
Nidesha Randeni, Matteo Bordiga, Baojun Xu

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(17), P. 9366 - 9366

Published: Aug. 29, 2024

The human gastrointestinal tract hosts a complex and dynamic community of microorganisms known as the gut microbiota, which play pivotal role in numerous physiological processes, including digestion, metabolism, immune function. Recent research has highlighted significant impact diet on microbiota composition functionality, consequential effects host health. Concurrently, there is growing evidence linking to inflammation, key factor many chronic diseases such inflammatory bowel disease (IBD), obesity, diabetes, cardiovascular (CVDs). This review explores how dietary components influence composition, these microbial changes affect pathways, therapeutic implications modulating this axis for prevention management. Beneficial patterns, Mediterranean (MD) plant-based diets, promote diverse balanced supporting anti-inflammatory pathways. Conversely, Western (WD), high saturated fats refined sugars, associated with dysbiosis increased inflammation. With all links between three variables considered, attempts offer thorough examination triangle formed by food.

Language: Английский

Citations

18

A review on probiotics and dietary bioactives: Insights on metabolic well-being, gut microbiota, and inflammatory responses DOI Creative Commons
Alice Njolke Mafe, Great Iruoghene Edo,

Osamah S. Majeed

et al.

Food Chemistry Advances, Journal Year: 2025, Volume and Issue: 6, P. 100919 - 100919

Published: Feb. 11, 2025

Language: Английский

Citations

6

The frontier of health: Exploring therapeutic potentials of the microbiome DOI

Mohammad Abavisani,

Sobhan Karbas Foroushan, Prashant Kesharwani

et al.

PharmaNutrition, Journal Year: 2025, Volume and Issue: unknown, P. 100435 - 100435

Published: Feb. 1, 2025

Language: Английский

Citations

2

Interplay of n-3 Polyunsaturated Fatty Acids, Intestinal Inflammation, and Gut Microbiota in Celiac Disease Pathogenesis DOI Open Access
Karla A. Bascuñán,

Magdalena Araya,

Juan M. Corchado

et al.

Nutrients, Journal Year: 2025, Volume and Issue: 17(4), P. 621 - 621

Published: Feb. 9, 2025

Celiac disease (CD) is a chronic autoimmune disorder driven by both genetic and environmental factors, with the HLA DQ2/DQ8 genotypes playing central role in its development. Despite predisposition, only small percentage of individuals carrying these develop disease. Gluten, protein found wheat, rye, barley, primary trigger, but other such as intestinal microbiota, may also contribute to progression. While gluten-free diet (GFD) remains cornerstone treatment, many CD patients experience persistent inflammation gut dysbiosis, leading ongoing symptoms complications. This inflammation, which impairs nutrient absorption, increases risk malnutrition, anemia, disorders. Recent studies have identified an altered microbiota patients, on off GFD, highlighting potential pathogenesis. An emerging area interest supplementation n-3 polyunsaturated fatty acids (PUFAs), known for their anti-inflammatory properties, therapeutic strategy. PUFAs, fish oil certain plant oils, modulate immune cell function cytokine production, making them promising intervention controlling CD. review explores current understanding PUFAs' effects microbiota's composition CD, goal identifying new avenues complementary treatments improve management.

Language: Английский

Citations

2

Gut microbiota and type 1 diabetes: a two-sample bidirectional Mendelian randomization study DOI Creative Commons

Manjun Luo,

Mengting Sun, Tingting Wang

et al.

Frontiers in Cellular and Infection Microbiology, Journal Year: 2023, Volume and Issue: 13

Published: May 29, 2023

Objective The real causal relationship between human gut microbiota and T1D remains unclear difficult to establish. Herein, we adopted a two-sample bidirectional mendelian randomization (MR) study evaluate the causality T1D. Methods We leveraged publicly available genome-wide association (GWAS) summary data perform MR analysis. microbiota-related GWAS from 18,340 individuals international consortium MiBioGen were used. statistic for (n = 264,137) obtained latest release FinnGen as outcome of interest. selection instrumental variables conformed strictly series preset inclusion exclusion criteria. MR-Egger, weighted median, inverse variance (IVW), mode methods used assess association. Cochran’s Q test, MR-Egger intercept leave-one-out analysis conducted identify heterogeneity pleiotropy. Results At phylum level, only Bacteroidetes was indicated have on (OR 1.24, 95% CI 1.01-1.53, P 0.044) in IVW When it comes their subcategories, Bacteroidia class 1.28, 1.06-1.53, 0.009, FDR 0.085), Bacteroidales order Eubacterium eligens group genus 0.64, 0.50-0.81, 2.84×10 -4 , 0.031) observed with No pleiotropy detected. Conclusions present reports that phylum, class, causally increase risk, whereas genus, which belongs Firmicutes decreases risk. Nevertheless, future studies are warranted dissect underlying mechanisms specific bacterial taxa’s role pathophysiology

Language: Английский

Citations

34

Rheumatoid arthritis and the intestinal microbiome: probiotics as a potential therapy DOI Creative Commons
Yang Yang, Qing Hong,

Xuehong Zhang

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: March 6, 2024

Rheumatoid arthritis (RA) is a systemic autoimmune disorder characterized by swollen joints, discomfort, stiffness, osteoporosis, and reduced functionality. Genetics, smoking, dust inhalation, high BMI, hormonal gut microbiota dysbiosis are all likely causes of the onset or development RA, but underlying mechanism remains unknown. Compared to healthy controls, patients with RA have significantly different composition microbiota. It well known that human plays key role in initiation, maintenance, operation host immune system. Gut has local systematic adverse effects on system, resulting susceptibility various diseases, including RA. Studies intestinal modulation immunomodulatory properties probiotics been reported, order identify their potential possibility prevention disease activity control This review summarized current studies mechanisms progression as preventative therapeutic Additionally, we proposed challenges difficulties application providing direction for research

Language: Английский

Citations

12

Gut microbiota and their metabolites in the immune response of rheumatoid arthritis: Therapeutic potential and future directions DOI
Xiaoyu Cai,

Fujia Ren,

Yao Yao

et al.

International Immunopharmacology, Journal Year: 2025, Volume and Issue: 147, P. 114034 - 114034

Published: Jan. 12, 2025

Language: Английский

Citations

1